Health system executives and boards of directors are likely to encounter four areas of concern as they recover from the pandemic’s impact and prepare for the future.

In this episode of Looking Ahead, Indivar Khosla, Microsoft’s Vice President of Financial Services, US, forecasts which digital capabilities can help financial services differentiate themselves from their competitors.

To hear more from Microsoft on the future of financial services and to gain additional insights from industry leaders and inspirational change agents, join us in attending Envision: U.S. Financial Services Summit Series on May 12, 2021.

What role should the board play when it comes to digital transformation? In this episode of Looking Ahead, we gain the perspective of three executives from Crowe on how the board can assess their current delivery models, consult the proper leaders on their team when considering a digital shift and measure the results of a transformation project.

Directors and senior executives have critical roles to play in leading the effort to digitally transform companies of all sizes and in all industries.

The 2020 presidential election is around the corner. A Crowe cybersecurity professional explores whether American voting infrastructure is at risk of election hacking.

While hospitals and other healthcare firms provide frontline protection against Covid-19, scammers and hackers have used the confusion to attack. And many healthcare boards have ignored cybersecurity, leaving organizations vulnerable.

Internal audit is grappling with the whirlwind of technological change—everything from blockchain to artificial intelligence to digital transformation. What use is internal audit in an age of such revolution? It turns out, a lot.

Equifax became the poster child for cybersecurity disasters when hackers breached its systems in 2017, exposing the Social Security numbers of 146 million people, about half the U.S. population. Not only did its CEO and senior executives lose their jobs, the company paid a settlement with multiple agencies as high as $700 million.

Kison Patel, the CEO of software company DealRoom, remembers working for a private equity firm trying to do a deal not long ago. His firm bombarded the target company with requests for information — including repetitive requests for the same information, often in Excel spreadsheets. Eventually, the seller got fed up and walked away.

Artificial intelligence and big data offer some of the most exciting prospects for medicine. But making good use of the data is another story.